News Newly Identified Type of Immune Cells May Affect Lung Fibrosis Progression, Study Shows

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall The Good, Bad, and Ugly Truths of Living with Pulmonary Fibrosis

News Senolytic Treatment Improves Physical Function in IPF Patients, According to Small Pilot Study

Columns, Just Breathe...Compassionate Help for the PF Journey Dealing with a Recent Exacerbation

News Size of Healthy Lung Area Can Help Predict Survival in CPFE Patients with Lung Cancer, Study Says

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall Introducing Your Chronic Illness in a New Relationship

Esbriet, News Esbriet Reduces Risk of IPF Progression Over One Year, Pooled Analysis Shows

News Sprycel/Quercetin Combo Therapy Improves Physical Function in IPF Patients, Phase 1 Trial Shows

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall New Year’s Resolutions from a PF Patient: Focusing On Myself

News Phase 1 Study of Potential IPF Therapy, PLN-74809, Doses 1st Group, Pliant Says

Columns, Just Breathe...Compassionate Help for the PF Journey Setting Goals for the New Year

News Promedior’s Experimental IPF Therapy PRM-151 to Enter Phase 3 Stage

News Galapagos Launches Global ISABELA Program Testing GLPG1690 in IPF Patients

News Targeting IGFBP-5 May Be Viable Strategy to Treat Pulmonary Fibrosis, Preclinical Study Finds

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall A Gratitude Miniseries: December 2018

News Top 10 Pulmonary Fibrosis Stories of 2018

News Columnist and Advocate Kim Fredrickson Chronicles PF Journey in New Book to Guide Others

News Mutation Prevents Mucus Clearance in Small Airways, Raising IPF Risk, Study Says

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall Self-help Tips for When IPF Becomes Overwhelming

News Rising Healthcare Costs Strain EU Budgets Even as New Therapies Flourish

News FDA Approves the Launch of Clinical Trials to Assess IPF Candidate BBT-877

Columns, Just Breathe...Compassionate Help for the PF Journey Adjusting Christmas Plans Due to Exhaustion

News Sustained-release Ofev Shows Better Absorption Over Soft Capsules, Study Suggests

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall I’m Seeking Solutions to Workplace Struggles

News Potential Role of Ninj1 Protein in Promoting Pulmonary Fibrosis Uncovered in Study

News Cancer Therapy Panobinostat Shows Anti-fibrotic Effects in IPF Fibroblasts, Preclinical Study Reports

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall Grieving the Workplace Skills I’ve Lost Due to IPF

News 4MGS Test Predicts IPF Patient Mortality, Hospitalization, Study Says

Columns, Just Breathe...Compassionate Help for the PF Journey Self-compassion Helps Us Deal with Pulmonary Fibrosis

News Nasal Sampling May Be Fast and Noninvasive Way to Identify and Manage IPF, Study Suggests

News Veracyte Expands Early Access to Envisia Genomic Classifier Test for IPF Diagnosis

Esbriet, News Esbriet Extends IPF Patient Survival, Real-world Study Reports

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall Tips to Conserve Energy During Holiday Gatherings

News Nuformix’s NXP002 Candidates Show Potential Against IPF in ‘In-Patient’ Preclinical Model

Columns, Just Breathe...Compassionate Help for the PF Journey Using Technology to Get Help

News Late-stage IPF Patients Have Progressively Worse Quality of Life, Real-world Study Reports  

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall A Gratitude Miniseries: November 2018

News Potential Anti-Fibrotic Oral Treatment, RXC006, Shows Promise in Early Studies, Redx Announces

News Reduced Lung Function Linked to Increased Risk of Dementia, Cognitive Impairment, Study Reveals

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall Since My Diagnosis, I Experience ‘FOMO’ at a Deeper Level

News Herbal Extract of Traditional Medicine Works to Ease Lung Inflammation and Fibrosis, Early Study Reports

News Pre-existing PF Increases Risk of Lung Inflammation Among Lung Cancer Patients Using Opdivo or Keytruda, Study Suggests

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall I Take Extra Steps to Protect My Lungs as a Pulmonary Fibrosis Patient

News Blood Decorin Levels May Serve as Prognostic Marker for IPF Patients After Acute Exacerbation, Study Finds

News Phase 1 Trial of IPF Candidate Therapy BBT-877 Planned for January

Columns, Just Breathe...Compassionate Help for the PF Journey I Hope My Book Will Help You on Your PF Journey

News IGFBP-5 Protein Promotes Fibrosis by Increasing Pro-Fibrotic Factors, Study Reports

News LOXL2 Inhibitor PXS-5382A Shows Potential to Treat IPF, Other Fibrotic Diseases in Phase 1 Trial

News Redx Pharma to Update on Potential IPF Therapy, Including Those with Advanced Disease

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall An Unexpected Difficulty of Living with PF: Cognitive Challenges

News Ofev Maintains Effectiveness in Advanced IPF Patients, Real-world Study Shows

Columns, Just Breathe...Compassionate Help for the PF Journey The Benefits of Doing Pulmonary Rehab Online

News Ouabain Treatment Reduces Idiopathic Pulmonary Fibrosis Symptoms in Mice

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall Saying ‘I’m Sick’ Could Mean Many Things. Here’s Why

News Poor Lung Function Before Starting Ofev Seen as Main Reason for Halting Use in UK Real-world Study

News Early Phase 2 Data Support Testing GKT831 in IPF, Continuing Work with Other Fibrotic Diseases

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall The Pros and Cons of Connecting with Fellow IPF Patients

News BML-111 Found to Suppress Lung Fibrosis in Mouse Model by Inhibiting Signaling Molecules

Columns, Just Breathe...Compassionate Help for the PF Journey I’ve Tackled Another of My Heartfelt Goals — You Can, Too

Esbriet, News No New Safety Concerns with Esbriet, Results from Long-term PASSPORT Study Show

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall A Gratitude Miniseries: October 2018

News Phase 2 Trial Now Underway to Test Galapagos’ GLPG1205 in IPF Patients

News Ofev of Less Benefit to Severe IPF Patients But Those Who Can Stay on Therapy Gain, Study Finds

News Lung Cancer Has High Incidence, Worse Prognosis Among IPF Patients, Study Finds

Columns, Just Breathe...Compassionate Help for the PF Journey Missing Meaningful Moments Due to PF

News Galecto Raises About $90M to Support New Phase 2/3 Trial to Test Inhaled TD139 for IPF

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall What I Need from Others as a Patient with Pulmonary Fibrosis

News #NORDSummit – Major Issues on Table for Rare Disease Patients in US as Midterm Elections Approach

News East River BioSolutions Awarded Grant to Develop Tools to Aid Lab Research on IPF

News IPF and Interstitial Lung Disease in Rheumatoid Arthritis Share Genetic Risk Factor

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall The Power of Kindness in My Battle Against IPF

News Mesenchymal Stem Cells from IPF Patients Show Impact of Disease, Study Says

Columns, Just Breathe...Compassionate Help for the PF Journey How to Decide When to Stop Working

News PF Foundation Invites Promising Researchers to Apply to PFF Scholars Program

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall I’ve Shifted My Attitude Toward Self-care

News PFF Opens Educational Site to Help People Better Understand Disease and Its Symptoms

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall Living with IPF and Navigating the Changes

News Researchers Discover New Targets to Inhibit Pulmonary Fibrosis

Columns, Just Breathe...Compassionate Help for the PF Journey Let’s Treat Ourselves with Kindness

News Pharmaxis’ LOXL2 Inhibitor Shows Positive Results in Phase 1 Trial in Healthy Volunteers

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall Forming Meaningful Friendships with a Chronic Illness

Esbriet, News Analysis of Phase 3 Trial Data Shows Benefits of Esbriet for More Advanced IPF Patients

News Advocacy Groups, Doctors Question Rising Prices of Rare Disease Treatments

Columns, Just Breathe...Compassionate Help for the PF Journey Taking Time to Express Gratitude

News Ofev Prevented Lung Cancer Progression in IPF Patient, Case Report Shows

News X-Rx Completes Early Studies on X-165 for Potential IPF Treatment, Supporting IND Application

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall A Gratitude Miniseries: September 2018

News Ofev, Sildenafil Combo Shows No Added Benefit in IPF Patients with Poor Lung Function, Study Shows

News Veracyte to Present New Results on Genomic Classifiers at CHEST 2018

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall As a PF Patient, I’m Begging You to Please Be Considerate of Where You Smoke

News Endometrial Regenerative Cells a Potential New Therapy for PF, Mouse Study Reports

Esbriet, News Esbriet and Ofev Show Significant Benefits in Real-Life Clinical Setting

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall Addressing Stares from Others

News Samumed and United Therapeutics Partner to Advance Potential IPF Inhalation Therapy, SM04646

Columns, Just Breathe...Compassionate Help for the PF Journey Practicing Self-care Is Crucial During Medical Testing

News Corbus Pharmaceuticals Expands Its Portfolio With Hundreds of Potential New Agents from Jenrin Discovery

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall Why I Love Traveling Despite IPF Complications

News Respivant Sciences Opens with Focus on Treating Chronic Cough in IPF Patients

News #NORDSummit – More Than 700 Expected to Attend Oct. 15-16 Rare Disease Summit in Washington

News Long-term Use of Ofev Safely Slows IPF Progression, New Phase 3 Extension Trial Data Show